Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the ...
Sep 10, 2018
0
14
By destroying the regulatory genes of the AIDS virus HIV-1 using the genome editing system CRISPR/Cas9, a Japanese research group has succeeded in blocking the production of HIV-1 by infected cells.
May 18, 2018
1
33
A bioinformatic examination of HIV mutations documented in clinics could help guide the selection of antiretroviral therapies.
Sep 20, 2017
0
2
Researchers at Johns Hopkins Medicine report new evidence that immune cells infected with a latent form of human immunodeficiency virus (HIV) are able to proliferate, replenishing the reservoir of virus that is resistant ...
May 30, 2017
0
1
A group of researchers at the Centre for Genomic Regulation (CRG) and the Pompeu Fabra University (UPF) in Barcelona, Spain, have developed a new technology that sheds light on the HIV infection and offers a first glance ...
Nov 23, 2016
0
0
Using gene editing technology, researchers at the Lewis Katz School of Medicine at Temple University have, for the first time, successfully excised a segment of HIV-1 DNA - the virus responsible for AIDS - from the genomes ...
May 19, 2016
0
79
HIV mutates rapidly and forms countless virus variants in the patient. A collaboration of scientists from the group of Richard Neher, Max Planck Institute for Developmental Biology in Tübingen, Germany, and scientists from ...
Dec 17, 2015
0
7
The virus that causes AIDS is an efficient and crafty retrovirus. Once HIV inserts its DNA into the genome of its host cells, it has a long incubation period, and can remain dormant and hidden for years. And while physicians ...
Apr 9, 2015
0
200
Genomic medicine is rapidly developing, bringing with its advances promises of individualized genetic information to tailor and optimize prevention and treatment interventions. Genetic tests are already guiding treatments ...
Sep 23, 2014
0
0
Fifteen years ago, MIT professor John Essigmann and colleagues from the University of Washington had a novel idea for an HIV drug. They thought if they could induce the virus to mutate uncontrollably, they could force it ...
Jul 28, 2014
1
0
